Profile picture

Doctor Helena Santos Moreira

Sao Joao University Hospital Centre, Porto (Portugal)
Membership: ESC Professional Member HFA Member
Follow
Logo ESC

Contributor content

Apical hypertrophic cardiomyopathy in a real-world cohort: phenotypic features, sudden cardiac death risk assessment and clinical outcomes
Presentation
Apical hypertrophic cardiomyopathy in a real-world cohort: phenotypic features, sudden cardiac death risk assessment and clinical outcomes
Beyond the genotype: prevalence, phenotypic expression and prognosis in hypertrophic cardiomyopathy
Presentation
Beyond the genotype: prevalence, phenotypic expression and prognosis in hypertrophic cardiomyopathy
Are variants of uncertain significance clinically equivalent to genotype-negative status in hypertrophic cardiomyopathy? A single-center analysis
Presentation
Are variants of uncertain significance clinically equivalent to genotype-negative status in hypertrophic cardiomyopathy? A single-center analysis
Prevalence of eligibility for dual GIP/GLP-1 receptor agonists among non-diabetic and overweight adults - a Portuguese community-based study
Presentation
Prevalence of eligibility for dual GIP/GLP-1 receptor agonists among non-diabetic and overweight adults - a Portuguese community-based study
Real-world applicability of a risk prediction score in apical hypertrophic cardiomyopathy
Presentation
Real-world applicability of a risk prediction score in apical hypertrophic cardiomyopathy
Real-world performance of current sudden cardiac death risk stratification tools in hypertrophic cardiomyopathy: a single-centre study
Presentation
Real-world performance of current sudden cardiac death risk stratification tools in hypertrophic cardiomyopathy: a single-centre study
Predictors of heart failure with reduced or mildly reduced ejection fraction development in hypertrophic cardiomyopathy: a single-centre study
Presentation
Predictors of heart failure with reduced or mildly reduced ejection fraction development in hypertrophic cardiomyopathy: a single-centre study
Primary prevention of sudden cardiac death in in hypertrophic cardiomyopathy: are we calibrating arrhythmic risk correctly?
Presentation
Primary prevention of sudden cardiac death in in hypertrophic cardiomyopathy: are we calibrating arrhythmic risk correctly?
Phenotypic impact of sarcomeric versus non-sarcomeric genetic variants in hypertrophic cardiomyopathy: a real-world analysis
Presentation
Phenotypic impact of sarcomeric versus non-sarcomeric genetic variants in hypertrophic cardiomyopathy: a real-world analysis
When STEMI strikes in pregnancy: a race against time
Presentation
When STEMI strikes in pregnancy: a race against time

ESC 365 is supported by